About Rui Yi
Rui Yi is a company based in Shanghai (China) founded in 2018. Rui Yi operates in a competitive market with competitors including Omniome, HitGen, Rejuvenate Bio, Novogene Corporation and NovellusDx, among others.
- Headquarter Shanghai, China
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Realbio Advanced Systems Private Limited
- Date of Incorporation 17 Aug, 2018
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
$96.78 K (USD)15.36as on Mar 31, 2022
-
Net Profit
$693.06 (USD)708.81as on Mar 31, 2022
-
EBITDA
$1.58 K (USD)116.54as on Mar 31, 2022
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Rui Yi
Detailed funding history for Rui Yi
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Rui Yi
Investment portfolio details for Rui Yi
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Rui Yi
Detailed financials for Rui Yi
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Rui Yi Comparisons
Peer comparison for Rui Yi
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Rui Yi
Rui Yi operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Omniome, HitGen, Rejuvenate Bio, Novogene Corporation and NovellusDx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genome sequencing platform is provided for clinical diagnostics.
|
|
| Locked | Locked | Locked |
DNA-encoded libraries are developed for drug discovery applications.
|
|
| Locked | Locked | Locked |
Gene-editing platform and anti-aging therapy for dogs are developed.
|
|
| Locked | Locked | Locked |
Genomic services and solutions with NGS expertise are provided.
|
|
| Locked | Locked | Locked |
Developer of technology for precision cancer diagnosis and therapies
|
|
| Locked | Locked | Locked |
Meta-genomics platforms and services for microbiome studies are provided.
|
Detailed competitors of Rui Yi
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Rui Yi
Complete news archive for Rui Yi
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rui Yi
Rui Yi was founded in 2018.
Rui Yi is headquartered in Shanghai, China.
Annual revenue of Rui Yi is $96.78K as on Mar 31, 2022.
Rui Yi was founded in 2018 in Shanghai, China, within the biological gene technology and health services sector. High-throughput sequencing and personalized big data analysis solutions are provided to major hospitals and medical centers. Medical services are extended to end customers, while diagnostic techniques for bacteria incubation, livestock management, nutrition, and disease control are developed. Operations focus on genomics applications across healthcare and agricultural domains.
Rui Yi's top competitors include Novogene Corporation, BGI and Omniome.